Attovia Therapeutics
在场
高管
查看带有其 15 名主要高管的组织结构图
Attovia Therapeutics 搜索最多的简介
- Tao Fu, Chief Executive Officer and Director
- Jamie Topper, Chairman of the Board
- Colin Walsh, Director
高管在Attovia Therapeutics变化
- Steven Chan已作为Chief Financial Officer加入公司 (新闻发布的2024十月16号).
- Angie You已作为Director加入公司 (新闻发布的2024七月10号).
- Mitchell Gold已作为Director加入公司 (新闻发布的2024七月10号).
创建提醒
跟踪 Attovia Therapeutics 的高管变动
生物技术
Attovia Therapeutics 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Attovia Therapeutics 的最新新闻稿
- Attovia Therapeutics Appoints Chief Financial Officer
- Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
- Attovia Announces Second Tranche Closing of $60 Million Series A Financing and Highlights Progress Building a Best-in-Class Pipeline Leveraging the Attobody™ Platform
- Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
- Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
- News & Media - ATTOVIA
- Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform
- View more press releases Close
通过电子邮件
